Summary
The effect of clonidine on a number of behavioural parameters believed to be expressed through central dopaminergic mechanisms has been studied in rodents.
-
1.
Clonidine (0.06–2 mg/kg) potentiated the circling response to standard doses of both apomorphine (0.25 mg/kg) and amphetamine (3 mg/kg) in mice with unilateral destruction of nigro-neostriatal dopamine nerve terminals. Similarly, clonidine (0.06–2 mg/kg) enhanced the locomotor effect of apomorphine in reserpinised mice.
-
2.
Clonidine (0.5 mg/kg) was without effect on the patterns of stereotyped behaviours induced by the dopamine agonist apomorphine (0.1–5 mg/kg) in the rat. Unilateral intrastriatal injections of clonidine (5–100 μg) caused no discernable behavioural effects in rats.
-
3.
Injection of apomorphine (10 μg) bilaterally into the region of the nucleus accumbens of the rat resulted in a hyperactive response, while bilateral injection of clonidine (50 μg) into this region caused marked sedation, thus mimicking the effects of these drugs on motor activity when administered systemically. Combinations of systemic or nucleus accumbens apomorphine and clonidine resulted in potentiated stereotypy and prolonged hyperactivity responses.
-
4.
Clonidine (0.5 mg/kg) potentiated the cataleptic effect of the dopamine antagonist haloperidol (0.1–2 mg/kg) in rats.
Clonidine therefore potentiated those behavioural responses exhibiting a locomotor component (viz. circling and hyperactivity), but was without effect on stereotypy. The potentiation of catalepsy induced by clonidine may be explained in non-specific sedatory terms.
It is apparent that clonidine acts through a secondary neurone system which modifies the effects of dopamine receptor stimulation, although the exact site of this interaction is not clear. The tentative conclusion might be that clonidine inhibits 5-HT neuronal activity, and the possible relationships between 5-HT and NA and dopamine are discussed.
Similar content being viewed by others
References
Andén, N.-E., Strömbom, U.: Adrenergic receptor blocking agents: effects on central noradrenaline and dopamine receptors and on motor activity. Psychopharmacologia (Berl.) 38, 91–103 (1974)
Andén, N. E., Corrodi, H., Fuxe, K., Hökfelt, B., Hökfelt, T., Rydin, C., Svensson, T.: Evidence for a central noradrenaline receptor stimulation by clonidine. Life Sci. 9, (1), 513–523 (1970)
Andén, N.-E., Strömbom, U., Svensson, T. H.: Dopamine and noradrenaline receptor stimulation: reversal of reserpine-induced suppression of motor activity. Psychopharmacologia (Berl.) 29, 289–298 (1973)
Andén, N.-E., Grabowska, M., Strömbom, U.: Different alpha-adrenoreceptors in the central nervous system mediating biochemical and functional effects of clonidine and receptor blocking agents. Naunyn-Schmiedeberg's Arch. Pharmacol. 292, 43–52 (1976)
Baldessarini, R. J., Amatruda, T. T., Griffith, F. F., Gerson, S.: Differential effects of serotonin on turning and stereotypy induced by apomorphine. Brain Res. 93, 158–163 (1975)
Costall, B., Naylor, R. J.: On the mode of action of apomorphine. Europ. J. Pharmacol. 21, 350–361 (1973)
Costall, B., Olley, J. E.: Cholinergic and neuroleptic-induced catalepsy: modification by lesions in the caudate putamen. Neuropharmacology 10, 297–306 (1971)
Costall, B., Fortune, D. H., Naylor, R. J., Marsden, C. D., Pycock, C.: Serotonergic involvement with neuroleptic catalepsy. Neuropharmacology 14, 859–868 (1975)
Costall, B., Naylor, R. J., Marsden, C. D., Pycock, C. J.: Serotoninergic modulation of the dopamine response from the nucleus accumbens. J. Pharm. Pharmacol. 28, 523–526 (1976)
Farnebo, L.-O., Hamberger, B.: Drug-induced changes in the release of 3H-monoamines from field stimulated rat brain slices. Acta physiol. scand., Suppl. 371, 35–44 (1971)
Fibiger, H. C., Campbell, B. A.: The effect of parachlorophenylalanine on spontaneous locomotor activity in the rat. Neuropharmacology 10, 25–32 (1971)
Green, A. R., Grahame-Smith, D. G.: The role of brain dopamine in the hyperactivity syndrome produced by increased 5-hydroxytryptamine synthesis in rats. Neuropharmacology 13, 949–959 (1974)
Jackson, D. M., Andén, N.-E., Dahlström, A.: A functional effect of dopamine in the nucleus accumbens and in some other dopamine-rich parts of the rat brain. Psychopharmacologia (Berl.) 45, 139–149 (1975)
Jacobs, B. L., Trimbach, C., Eubanks, E. E., Trulson, M.: Hippocampal mediation of raphe lesion- and PCPA-induced hyperactivity in the rat. Brain Res. 94, 253–261 (1975)
Karppanen, H., Paakkari, I., Paakkari, P., Huotari, R., Orma, A.-L.: Possible involvement of central histamine H2-receptors in the hypotensive effect of clonidine. Nature (Lond.) 259, 587–588 (1976)
König, J. F. R., Klippel, R. A.: The rat brain. Baltimore: Williams and Wilkins Co. 1963
Kostowski, W., Samanin, R., Bareggi, S. R., Marc, V., Garattini, S., Valzelli, L.: Biochemical aspects of the interaction between midbrain raphe and locus coeruleus in the rat. Brain Res. 82, 178–182 (1974)
Loizou, L. A.: Projections of the nucleus locus coeruleus in the albino rat. Brain Res. 15, 563–566 (1969)
Maj, J., Baran, L., Sowińska, H., Zieliński, M.: The influence of cholinolytics on clonidine action. Pol. J. Pharmacol. Pharm. 27, 17–26 (1975a)
Maj, J., Mogilnicka, E., Palider, W.: Serotoninergic mechanism of clonidine and apomorphine interaction. Pol. J. Pharmacol. Pharm. 27, 27–35 (1975b)
Milson, J. A., Pycock, C. J.: Effect of drugs acting on cerebral 5-hydroxytryptamine mechanisms on dopamine-dependent turning behaviour in mice. Brit. J. Pharmacol. 56, 77–85 (1976)
Modigh, K.: Functional aspects of 5-hydroxytryptamine turnover in the central nervous system. Acta physiol. scand., Suppl. 403, 1–56 (1974)
Munkvad, I., Pakkenberg, H., Randrup, A.: Aminergic systems in basal ganglia associated with stereotyped hyperactive behaviour and catalepsy. Brain Behav. Evol. 1, 89–100 (1968)
Pijnenburg, A. J. J., Honig, W. M. M., van Rossum, J. M.: Effects of antagonists upon locomotor stimulation induced by injection of dopamine and noradrenaline into the nucleus accumbens of nialamide-pretreated rats. Psychopharmacologia (Berl.) 41, 175–180 (1975)
Pycock, C. J.: Noradrenergic influences on dopamine-dependent behaviour in rats. Brit. J. Pharmacol. 57, 424P (1976)
Pycock, C. J., Donaldson, I., Mac, G., Marsden, C. D.: Circling behaviour produced by unilateral lesions in the region of the locus coeruleus in rats. Brain Res. 97, 317–329 (1975a)
Pycock, C. J., Tarsy, D., Marsden, C. D.: Inhibition of circling behaviour by neuroleptic drugs in mice with unilateral 6-hydroxydopamine lesions of the striatum. Psychopharmacologia (Berl.) 45, 211–219 (1975b)
Rochette, L., Bralet, J.: Effect of clonidine on the synthesis of cerebral dopamine. Biochem. Pharmacol. 24, 303–305 (1975a)
Rochette, L., Bralet, J.: Effect of the norepinephrine receptor stimulating agent ‘clonidine’ on the turnover of 5-hydroxytryptamine in some areas of the rat brain. J. Neural Trans. 37, 259–267 (1975b)
Rochette, L., Bralet, A.-M., Bralet, J.: Influence de la clonidine sur la synthèse et la libération de la noradrénaline dans différentes structures cérébrales du rat. J. Pharmacol. (Paris) 5, 209–220 (1974)
Roizen, M. F., Jacobowitz, D. M.: Studies on the origin of innervation of the noradrenergic area bordering on the nucleus raphe dorsalis. Brain Res. 101, 561–568 (1976)
Scheel-Krüger, J., Hasselager, E.: Studies of various amphetamines, apomorphine and clonidine on body temperature and brain 5-hydroxytryptamine metabolism in rats. Psychopharmacologia (Berl.) 36, 189–202 (1974)
Schmitt, H., Schmitt, H., Boissier, J. R., Giudicelli, J. F.: Centrally mediated decrease in sympathetic tone induced by 2-(2,6-dichlorophenylamino)2-imidazoline (St. 155). Europ. J. Pharmacol. 2, 147–148 (1967)
Starke, K., Montel, H.: Involvement of α-receptors in clonidine-induced inhibition of transmitter release from central monoamine neurones. Neuropharmacology 12, 1073–1080 (1973)
Strömbom, U.: Catecholamine receptor agonists. Effects on motor activity and rate of tyrosine hydroxylation in mouse brain. Naunyn-Schmiedeberg's Arch. Pharmacol. 292, 167–176 (1976)
Svensson, T.H., Bunney, B. S., Aghajanian, G. K.: Inhibition of both noradrenergic and serotonergic neurons in brain by the α-adrenergic agonist clonidine. Brain Res. 92, 291–306 (1975)
von Voigtlander, P. F., Moore, K. E.: Turning behaviour in mice with unilateral 6-hydroxydopamine lesions in the striatum: effects of apomorphine, d-Dopa, amantadine, amphetamine and other psychomotor stimulants. Neuropharmacology 12, 451–462 (1973)
Weiner, W. J., Goetz, C., Klawans, H. L.: Serotonergic and antiserotonergic influences on apomorphine-induced stereotyped behaviour. Acta pharmacol. (Kbh.) 36, 155–160 (1975)
Zwieten, P. A. van: The central action of anti-hypertensive drugs mediated via central α-receptors. J. Pharm. Pharmacol. 25, 89–95 (1973)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Pycock, C.J., Jenner, P.G. & Marsden, C.D. The interaction of clonidine with dopamine-dependent behaviour in rodents. Naunyn-Schmiedeberg's Arch. Pharmacol. 297, 133–141 (1977). https://doi.org/10.1007/BF00499922
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00499922